Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

395 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Among Patients With Three-Vessel Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From CREDO-Kyoto PCI/CABG Registry Cohort-3).
Matsumura-Nakano Y, Shiomi H, Morimoto T, Yamaji K, Ehara N, Sakamoto H, Takeji Y, Yoshikawa Y, Yamamoto K, Imada K, Tada T, Taniguchi R, Nishikawa R, Tada T, Uegaito T, Ogawa T, Yamada M, Takeda T, Eizawa H, Tamura N, Tambara K, Suwa S, Shirotani M, Tamura T, Inoko M, Nishizawa J, Natsuaki M, Sakai H, Yamamoto T, Kanemitsu N, Ohno N, Ishii K, Marui A, Tsuneyoshi H, Terai Y, Nakayama S, Yamazaki K, Takahashi M, Tamura T, Esaki J, Miki S, Onodera T, Mabuchi H, Furukawa Y, Tanaka M, Komiya T, Soga Y, Hanyu M, Ando K, Kadota K, Minatoya K, Nakagawa Y, Kimura T; On behalf the CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators. Matsumura-Nakano Y, et al. Among authors: imada k. Am J Cardiol. 2021 Apr 15;145:25-36. doi: 10.1016/j.amjcard.2020.12.076. Epub 2021 Jan 14. Am J Cardiol. 2021. PMID: 33454340
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CREDO-Kyoto PCI/CABG Registry Cohort-3).
Yamamoto K, Shiomi H, Morimoto T, Kadota K, Tada T, Takeji Y, Matsumura-Nakano Y, Yoshikawa Y, Imada K, Domei T, Kaneda K, Taniguchi R, Ehara N, Nawada R, Natsuaki M, Yamaji K, Toyofuku M, Kanemitsu N, Shinoda E, Suwa S, Iwakura A, Tamura T, Soga Y, Inada T, Matsuda M, Koyama T, Aoyama T, Sato Y, Furukawa Y, Ando K, Yamazaki F, Komiya T, Minatoya K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-3 investigators. Yamamoto K, et al. Among authors: imada k. Am J Cardiol. 2021 Apr 15;145:47-57. doi: 10.1016/j.amjcard.2020.12.078. Epub 2021 Jan 15. Am J Cardiol. 2021. PMID: 33454345
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Versus Without Chronic Kidney Disease.
Yamamoto K, Natsuaki M, Morimoto T, Shiomi H, Takeji Y, Kadota K, Imada K, Toyofuku M, Kanemitsu N, Shinoda E, Suwa S, Iwakura A, Tamura T, Soga Y, Inada T, Matsuda M, Koyama T, Aoyama T, Kato E, Sato Y, Furukawa Y, Ando K, Yamazaki F, Komiya T, Minatoya K, Nakagawa Y, Kimura T. Yamamoto K, et al. Among authors: imada k. Am J Cardiol. 2021 Apr 15;145:37-46. doi: 10.1016/j.amjcard.2020.12.079. Epub 2021 Jan 14. Am J Cardiol. 2021. PMID: 33454346
Effects of Acute Coronary Syndrome and Stable Coronary Artery Disease on Bleeding and Ischemic Risk After Percutaneous Coronary Intervention.
Natsuaki M, Morimoto T, Shiomi H, Kadota K, Tada T, Takeji Y, Matsumura-Nakano Y, Yoshikawa Y, Watanabe H, Yamamoto K, Imada K, Domei T, Yamaji K, Kaneda K, Taniguchi R, Ehara N, Nawada R, Toyofuku M, Shinoda E, Suwa S, Tamura T, Inada T, Matsuda M, Aoyama T, Sato Y, Furukawa Y, Ando K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators. Natsuaki M, et al. Among authors: imada k. Circ J. 2021 Oct 25;85(11):1928-1941. doi: 10.1253/circj.CJ-21-0016. Epub 2021 Apr 27. Circ J. 2021. PMID: 33907052 Free article.
Effect of Heart Failure on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Severe Coronary Artery Disease.
Yamamoto K, Matsumura-Nakano Y, Shiomi H, Natsuaki M, Morimoto T, Kadota K, Tada T, Takeji Y, Yoshikawa Y, Imada K, Domei T, Kaneda K, Taniguchi R, Ehara N, Nawada R, Yamaji K, Kato E, Toyofuku M, Kanemitsu N, Shinoda E, Suwa S, Iwakura A, Tamura T, Soga Y, Inada T, Matsuda M, Koyama T, Aoyama T, Sato Y, Furukawa Y, Ando K, Yamazaki F, Komiya T, Minatoya K, Nakagawa Y, Kimura T; CREDO‐Kyoto PCI/CABG Registry Cohort‐3 Investigators. Yamamoto K, et al. Among authors: imada k. J Am Heart Assoc. 2021 Aug 3;10(15):e021257. doi: 10.1161/JAHA.121.021257. Epub 2021 Jul 29. J Am Heart Assoc. 2021. PMID: 34323122 Free PMC article.
Effect of Polypharmacy on Long-Term Mortality After Percutaneous Coronary Intervention.
Yamamoto K, Natsuaki M, Morimoto T, Shiomi H, Ozasa N, Sakamoto H, Takeji Y, Imada K, Tada T, Taniguchi R, Uegaito T, Yamada M, Takeda T, Eizawa H, Suwa S, Shirotani M, Tamura T, Inoko M, Sakai H, Yamamoto T, Ishii K, Takahashi M, Tamura T, Miki S, Onodera T, Furukawa Y, Tanaka M, Ando K, Kadota K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-3 investigators. Yamamoto K, et al. Among authors: imada k. Am J Cardiol. 2021 Nov 15;159:19-29. doi: 10.1016/j.amjcard.2021.08.013. Epub 2021 Sep 6. Am J Cardiol. 2021. PMID: 34497005
395 results